Endocrine Society: Richard Ross, Laureate Award for Outstanding Innovation
Diurnal Group, a pharma firm specializing in therapies for chronic endocrine diseases, announces that director and chief scientific officer Richard Ross has been recognized by the Society’s 2021 Laureate Awards for Outstanding Innovation. The program salutes achievements in endocrinology, including innovations in research and clinical care.
“The Laureate Award is recognition of the pioneering research we have developed at Diurnal and an inspiration to the team to continue our work of developing new treatments for patients with unmet needs in endocrine diseases,” Ross said.
The award will be presented to Ross at ENDO 2021, the Endocrine Society’s annual meeting, in March 2021.
